John Holtz Email & Phone Number
Immunology and Retinal Products Early Assets Team Leader @ Boehringer Ingelheim
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
John Holtz Location
- Hartford, CT, US
John Holtz Work
- Immunology and Retinal Products Early Assets Team Leader @ (November 2024 - Present)
- Early Assets Team Leader - GI and Inflammation @ (April 2024 - November 2024)
- Associate Medical Director @ ASLAN Pharmaceuticals (January 2022 - April 2024)
- Associate Medical Director @ (March 2021 - January 2022)
- Medical Research Liaison @ (August 2020 - February 2021)
- Medical Science Liaison @ (January 2018 - September 2020)
- Executive Director @ (January 2016 - August 2017)
- Director and Team Leader @ (May 2014 - December 2015)
- Director @ (January 2010 - May 2014)
- Director @ (January 2008 - January 2009)
- Senior Manager @ (January 2001 - January 2007)
- Manager @ (January 1998 - January 2001)
John Holtz Education
- University of Pittsburgh Joseph M. Katz Graduate School of Business
MBA (Marketing)
1997-1998 - University of Pittsburgh
Ph.D. (Chemistry)
1991-1997 - Kaunas University of Technology
Exchange (Chemistry and Russian)
1990-1991 - Moscow Power Engineering Institute (Technical University)
Exchange (Chemistry)
1989-1991 - Rose-Hulman Institute of Technology
BS (Chemistry)
1987-1990 - Boonsboro High School 1983-1987
John Holtz Skills
- Immunology
- Neuroscience
- Pain Management
- Medicine
- Pharmaceutical Industry
- Biotechnology
- Clinical Development
- Clinical Trials
- Lifesciences
- Drug Discovery
- Product Development
- Inflammation
- Oncology
- Technology Transfer
- Drug Development
- Regulatory Affairs
- Commercialization
- FDA
- Pharmaceutical Sales
- Product Launch
- Infectious Diseases
- Clinical Research
- Biochemistry
- Chemistry
- Cardiology
- Biopharmaceuticals
- CRO
- GCP
- Validation
- Life Sciences
- Managed Care
- Rheumatology
- Neurology
- Pharmacovigilance
- Molecular Biology
- Regulatory Submissions
- Microsoft Excel
- Strategy
- Business Analysis
John Holtz Summary
- John Holtz, based in Hartford, CT, US, is currently a Immunology and Retinal Products Early Assets Team Leader at Boehringer Ingelheim. John Holtz brings experience from previous roles at Boehringer Ingelheim, ASLAN Pharmaceuticals and argenx. John Holtz holds a 1997 - 1998 MBA in Marketing @ University of Pittsburgh Joseph M. Katz Graduate School of Business. With a robust skill set that includes Immunology, Neuroscience, Pain Management, Medicine, Pharmaceutical Industry and more. John Holtz has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different John Holtz?
Find contact details for 700 million professionals.
Others Named John Holtz
John Holtz
Regional Sales Director
St. Augustine, FL, US
John Holtz
Immunology and Retinal Products Early Assets Team Leader
Hartford, CT, US
John Holtz
Vice President
Chicago, IL, US
John Holtz
President
Chandler, AZ, US
John Holtz
Senior Director - Market Development and Regulatory Affairs
Princeton, NJ, US
John Holtz
President
Sycamore, IL, US
John Holtz
Chief Financial Officer
Albuquerque, NM, US
John Holtz
Chief Strategy Officer (CSO)
Austin, TX, US
John Holtz
CEO
Leawood, KS, US
Top Boehringer Ingelheim Employees
Michael Betke-Hornfeck
Chief Purchasing Officer
Ingelheim am Rhein, RP, DE
Shashank Deshpande
Chairman of the Board of Managing Directors and Head of Human Pharma
Ingelheim am Rhein, RP, DE
Christoph Ruland
VP, General Manager, Human Pharma Germany
Ingelheim am Rhein, RP, DE
Mario Riesner
Head Global Operations HP (EVP)
Ingelheim am Rhein, RP, DE
Max Schrecklinger
CFO Human Pharma Business Unit
Ingelheim am Rhein, RP, DE
Ralf Dengler
Managing Director Site Head BIDACHEM SPA
Gau-Algesheim, RP, DE
Kerstin Walke
VP Analytical Development Biologicals
Ingelheim am Rhein, RP, DE
Clemens Twardy
Corporate Vice President, Head of Global Supply Chain and Lifecycle Management Animal Health
Ingelheim am Rhein, RP, DE
Ulrike Graefe-Mody
Corporate VP Head Translational Medicine, TA Cardiovascular, Renal and Metabolism
Ingelheim am Rhein, RP, DE
Manuel Kowarik
Vice President and Head of Global Supply Chain Management
Ingelheim am Rhein, RP, DE
Lutz Hampe
CRO Monitor Analytical Development Biologics
Warthausen, BW, DE
Karl Penz
EVP Head of Human Pharma Data and Analytics
Ingelheim am Rhein, RP, DE
Markus Schümmelfeder
CIO
Bavaria, Germany
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co